|Values are valid only on day of printing.|
Recommended for initial investigation of patients presenting at less than age 20 with a defect of neuromuscular transmission
Confirming that a recently acquired neurological disorder has an autoimmune basis
Distinguishing acquired myasthenia gravis from congenital myasthenic syndromes (persistently seronegative)
Providing a quantitative baseline for future comparisons in monitoring clinical course and response to immunomodulatory treatment
Note: Single antibody tests may be requested in follow-up of patients with positive results documented in this laboratory.
|Test ID||Reporting Name||Available Separately||Always Performed|
|ARBI||ACh Receptor (Muscle) Binding Ab||Yes||Yes|
|ARMO||ACh Receptor (Muscle) Modulating Ab||No||Yes|
See Myasthenia Gravis: Pediatric Diagnostic Algorithm in Special Instructions.